| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 04/27/2000 | WO2000000618A3 Polyketides and their synthesis |
| 04/27/2000 | WO1999064586A3 Phagocytic assay method |
| 04/27/2000 | CA2633345A1 A method of affinity separation and ligands for use therein |
| 04/27/2000 | CA2348153A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 04/27/2000 | CA2347062A1 Multiple domain glycoprotein hormones and methods of using |
| 04/27/2000 | CA2346798A1 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | CA2343974A1 Materials and methods involving conditional aggregation domains |
| 04/27/2000 | CA2343094A1 Interferon-beta fusion proteins and uses |
| 04/26/2000 | EP0994953A1 Expression system for production of therapeutic proteins |
| 04/26/2000 | EP0994899A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN ENDODERM |
| 04/26/2000 | CN1051769C Parathyroid hormone analogues, their production method and medicinal composition containing same |
| 04/25/2000 | US6054303 Cyclosporins conjugated at an alanine nitrogen atom to an immunogenic carrier, a ligand, a small organic compound or a label through a linker of alkylene oxide chain or carbonyloxybenzyl group including 1-3 carboxamide groups |
| 04/25/2000 | US6054284 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use |
| 04/22/2000 | CA2285749A1 Novel proteins from actinobacillus pleuropneumoniae |
| 04/20/2000 | WO2000022146A1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II |
| 04/20/2000 | WO2000022130A2 Metastatic breast and colon cancer regulated genes |
| 04/20/2000 | WO2000022126A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | WO2000022000A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 04/20/2000 | WO2000006605A9 Heterominibodies |
| 04/20/2000 | WO1999053062A3 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof |
| 04/20/2000 | CA2347968A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | CA2344711A1 Expression and secretion of icil-1 receptor antagonist type ii |
| 04/20/2000 | CA2343356A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 04/18/2000 | US6051688 Amino acid sequence for polypeptide of at least 6 contiguous amino acids; for diagnosis and treatment of nervous system disorders; anticonvulsants; antiischemic/antihypoxic agents; antiepileptic agents; alzheimer's/parkinson's diseases |
| 04/18/2000 | US6051418 Hybrid proteins with modified activity |
| 04/18/2000 | US6051384 Method of detecting p53-specific antibodies |
| 04/18/2000 | US6051232 Comprising allogenic chimeric major histocompatibility complex class i milecule; to induce tolerance to donor grafts when administered to the recipient at time of transplantation |
| 04/13/2000 | WO2000020607A2 Chimaeric proteins between members of tgf-beta superfamily |
| 04/13/2000 | WO2000020591A2 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 04/13/2000 | WO2000020581A1 Mage-a3 peptides presented by hla class ii molecules |
| 04/13/2000 | WO2000020574A2 Fusions of scaffold proteins with random peptide libraries |
| 04/13/2000 | WO2000020449A2 MODIFIED TGF-β SUPERFAMILY PROTEINS |
| 04/13/2000 | WO2000020448A2 Nlk1 -interacting proteins |
| 04/13/2000 | WO2000020446A2 Bax-mediated apoptosis modulating reagents and methods |
| 04/13/2000 | WO2000020445A2 Tumor antigens and ctl clones isolated by a novel procedure |
| 04/13/2000 | WO2000020434A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/13/2000 | WO2000001831A3 Proteases fused with variants of streptomyces subtilisin inhibitor |
| 04/13/2000 | WO1999055875A3 VACCINES CONTAINING RECOMBINANT PILIN AGAINST NEISSERIA GONORRHOEAE OR $i(NEISSERIA MENINGITIDIS) |
| 04/13/2000 | CA2657302A1 Modified tgf-.beta. superfamily proteins |
| 04/13/2000 | CA2347120A1 Nlk1 -interacting proteins |
| 04/13/2000 | CA2346070A1 Bax-mediated apoptosis modulating reagents and methods |
| 04/13/2000 | CA2345215A1 Fusions of scaffold proteins with random peptide libraries |
| 04/13/2000 | CA2344266A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/12/2000 | EP0991759A1 Ntn-2 member of tnf ligand family |
| 04/12/2000 | EP0991757A1 Novel tumor antigens |
| 04/11/2000 | CA1340958C Synthetic peptides representing a t-cell epitope as a carrier molecule for conjugate vaccines |
| 04/11/2000 | CA1340956C Synthetic peptides representing a t-cell epitope as a carrier molecule for conjugate vaccines |
| 04/09/2000 | CA2639637A1 Amino acid modified polypeptides |
| 04/06/2000 | WO2000018932A2 Receptor based antagonists and methods of making and using |
| 04/06/2000 | WO2000018896A1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 04/06/2000 | WO2000018881A2 Intein mediated peptide ligation |
| 04/06/2000 | WO1999066054A3 Erythropoietin analog-human serum albumin fusion protein |
| 04/06/2000 | WO1999055730A3 Polyepitope carrier protein |
| 04/06/2000 | WO1999051748A9 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 04/06/2000 | WO1996013594A8 Tumor-specific antibody fragments, fusion proteins, and uses thereof |
| 04/06/2000 | CA2344578A1 Polistinae venom phospholipase |
| 04/05/2000 | EP0990030A1 Transcriptional activators with graded transactivation potential |
| 04/05/2000 | CN1249433A NANBV diagnostics and vaccine |
| 04/04/2000 | US6045798 Membrane-associated immunogens of mycobacteria |
| 03/30/2000 | WO2000017373A1 Recombinant celo virus and celo virus dna |
| 03/30/2000 | WO2000017369A2 Alzheimer's disease secretase |
| 03/30/2000 | WO2000017364A2 Cyclin d polynucleotides, polypeptides and uses thereof |
| 03/30/2000 | WO2000017361A2 Interferon-epsilon |
| 03/30/2000 | WO2000017353A1 Ucp4 |
| 03/30/2000 | WO2000017221A1 Method of measuring protein-protein interactions in living cells |
| 03/30/2000 | WO1999060127A9 Il-17 homologous polypeptides and therapeutic uses thereof |
| 03/30/2000 | WO1999049892A3 Use of active p40 conjugates for nasal delivery |
| 03/30/2000 | CA2345392A1 Method of measuring protein-protein interactions in living cells |
| 03/30/2000 | CA2343697A1 Cyclin d polynucleotides, polypeptides and uses thereof |
| 03/30/2000 | CA2343004A1 Alzheimer's disease secretase |
| 03/30/2000 | CA2342773A1 Interferon-epsilon |
| 03/30/2000 | CA2339866A1 Recombinant celo virus and celo virus dna |
| 03/29/2000 | EP0988390A1 Alternatively targeted adenovirus |
| 03/29/2000 | EP0988376A2 Noey2 gene compositions and methods of use |
| 03/29/2000 | EP0988048A1 Ligand/lytic peptide compositions and methods of use |
| 03/29/2000 | EP0988047A1 Soluble ctla4 mutant molecules and uses thereof |
| 03/29/2000 | CN1248631A Fusion protein for immunoprophyaxis and immunotherapy of venereal disease and cancer |
| 03/28/2000 | US6043081 Expression vectors encoding recombinant proteins comprising a VPR/VPX virion incorporation domain for targeting into HIV-1 or HIV-2 virions |
| 03/28/2000 | US6043069 Catalytic antibodies and a method of producing same |
| 03/28/2000 | US6042832 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins |
| 03/28/2000 | CA2207278C Method of producing and purifying enzymes |
| 03/28/2000 | CA2140531C Method of increasing expression of viral proteins |
| 03/23/2000 | WO2000015796A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/23/2000 | WO2000015791A1 Ecdysone receptors and methods for their use |
| 03/23/2000 | WO2000015786A1 Metabotropic gaba receptor complex issued from the central nervous system |
| 03/23/2000 | WO2000015760A1 Streptococcal c beta protein compositions |
| 03/23/2000 | WO2000015758A2 Plant resistance to insect pests mediated by viral proteins |
| 03/23/2000 | WO2000015661A1 Modified e. coli enterotoxin ii signal peptide and a microorganism expressing a fusion protein of said peptide and a heterologous protein |
| 03/23/2000 | WO2000006747A3 Enzymes for biopolymer production |
| 03/23/2000 | CA2343577A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/23/2000 | CA2343574A1 Metabotropic gaba receptor complex issued from the central nervous system |
| 03/23/2000 | CA2343051A1 Streptococcal c beta protein compositions |
| 03/23/2000 | CA2340583A1 Plant resistance to insect pests mediated by viral proteins |
| 03/21/2000 | US6040430 Nucleic acid encoding site specific recombinase and nuclear receptor fusion protein |
| 03/21/2000 | US6040290 Antitumor agents for inhibiting the growth of adenocarcinoma cells |
| 03/21/2000 | US6040137 Amino acid sequence of antibody which specifically binds a certain antigen linked to amino acid sequence to which a certain antibody binds; immunoassay diagnostic reagents; therapy by redirecting specificity of patient's antibodies |
| 03/21/2000 | US6040136 Phagemid expression vector having a transcription regulatory sequence linked to gene encoding a fusion protein of a polypeptide and a bacteriophage coat protein; for library of proteins expressed in low quantity on particle surface |
| 03/16/2000 | WO2000014259A1 Candida boidinii strains having lowered protease activity and utilization thereof as host for producing foreign protein |
| 03/16/2000 | WO2000014257A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof |
| 03/16/2000 | WO2000014240A2 Attenuated salmonella sp12 mutants as antigen carriers |